Medtech VCs Find Ways To Fill The Gaps

The medtech venture capital ecosystem has certainly felt some strain lately as market pressures tighten the spigot for venture funding. At the IN3 meeting in October, members of a panel of medtech investors – three institutional and one corporate VC, and an entrepreneur – explained how they’re committing their capital during these difficult times.

There’s no doubt the medtech venture capital community is consolidating, but venture investors speaking on a panel at the recent IN3Medical Device 360°Summit in San Francisco said it’s not collapsing in upon itself. Instead, this retrenching is positioning venture capitalists to carefully fund the best ideas available.

The hope is that this tightening of capital will limit the number of so-called “me too” companies that have often...

More from Business Strategy

More from In Vivo